Implication of α2β1 integrin in anoikis of MCF-7 human breast carcinoma cells
G E Morozevich1, N I Kozlova, O Y Susova
1Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, 119121, Russia. 1938berman@gmail.com.
Abstract:
Silencing of α2β1 integrin expression significantly promoted anchorage-dependent apoptosis (anoikis) and drastically reduced clonal activity of MCF-7 human breast carcinoma cells. Depletion of α2β1 enhanced the production of apoptotic protein p53 and of inhibitor of cyclin-dependent protein kinases, p27, while downregulating antiapoptotic protein Bcl-2 and multifunctional protein cMyc. Blocking the expression of α2β1 had no effect on activity of protein kinase Akt, but it sharply increased the kinase activity of Erk1/2. Pharmacological inhibition of Erk1/2 had a minor effect on anoikis of control cells, while it reduced anoikis of cells with downregulated α2β1 to the level of control cells. The data show for the first time that integrin α2β1 is implicated in the protection of tumor cells from anoikis through a mechanism based on the inhibition of protein kinase Erk.
Insights
Integrin α2β1 protects breast cancer cells from anoikis (apoptosis). Silencing this integrin increases apoptosis by activating Erk1/2 signaling, revealing a new therapeutic target.
Area of Science:
- Cell Biology
- Molecular Oncology
Background:
- Integrins are crucial cell surface receptors mediating cell adhesion and signaling.
- Anoikis, or anchorage-dependent apoptosis, is a key process in preventing tumor metastasis.
- The role of integrin α2β1 in anoikis regulation in breast cancer remains incompletely understood.
Purpose of the Study:
- To investigate the role of integrin α2β1 in anoikis of MCF-7 human breast carcinoma cells.
- To elucidate the signaling pathways involved in integrin α2β1-mediated anoikis regulation.
Main Methods:
- Silencing of α2β1 integrin expression using specific inhibitors.
- Assessment of apoptosis, clonal activity, and protein expression (p53, p27, Bcl-2, cMyc).
- Analysis of protein kinase activity (Akt, Erk1/2) and pharmacological inhibition of Erk1/2.
Main Results:
- Downregulation of α2β1 integrin significantly promoted anoikis and reduced clonal activity.
- α2β1 depletion increased p53 and p27 levels while decreasing Bcl-2 and cMyc.
- Blocking α2β1 increased Erk1/2 activity but not Akt activity.
- Erk1/2 inhibition partially rescued cells from α2β1-depletion-induced anoikis.
Conclusions:
- Integrin α2β1 plays a significant role in protecting breast cancer cells from anoikis.
- This protection is mediated through the Erk1/2 signaling pathway.
- Targeting integrin α2β1 or Erk1/2 may offer novel therapeutic strategies for breast cancer treatment.
More Related Videos
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
Some...
01:15Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
01:10Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:31The Intrinsic Apoptotic Pathway
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...